Alkeon Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$98.8M Buy
1,850,934
+300,000
+19% +$16M 0.16% 44
2025
Q1
$62.8M Sell
1,550,934
-210,334
-12% -$8.51M 0.13% 48
2024
Q4
$49M Sell
1,761,268
-1,563,736
-47% -$43.5M 0.1% 53
2024
Q3
$95.4M Sell
3,325,004
-2,216
-0.1% -$63.6K 0.16% 45
2024
Q2
$78.1M Hold
3,327,220
0.13% 51
2024
Q1
$84M Sell
3,327,220
-437,000
-12% -$11M 0.14% 48
2023
Q4
$87.9M Sell
3,764,220
-3,160
-0.1% -$73.8K 0.2% 42
2023
Q3
$191M Buy
3,767,380
+300,000
+9% +$15.2M 0.34% 25
2023
Q2
$162M Buy
3,467,380
+246,650
+8% +$11.5M 0.28% 32
2023
Q1
$123M Sell
3,220,730
-23,185
-0.7% -$887K 0.27% 41
2022
Q4
$178M Buy
3,243,915
+81,656
+3% +$4.47M 0.69% 32
2022
Q3
$108M Buy
3,162,259
+542,588
+21% +$18.5M 0.35% 45
2022
Q2
$24.8M Buy
2,619,671
+200,000
+8% +$1.89M 0.07% 84
2022
Q1
$34.3M Sell
2,419,671
-60,000
-2% -$851K 0.07% 87
2021
Q4
$52.4M Hold
2,479,671
0.1% 91
2021
Q3
$55.4M Sell
2,479,671
-10,023
-0.4% -$224K 0.09% 92
2021
Q2
$61.8M Sell
2,489,694
-6,077
-0.2% -$151K 0.09% 87
2021
Q1
$72.4M Buy
2,495,771
+208,141
+9% +$6.04M 0.11% 83
2020
Q4
$59M Buy
2,287,630
+6,923
+0.3% +$179K 0.1% 85
2020
Q3
$70.2M Buy
2,280,707
+1,282,333
+128% +$39.5M 0.13% 76
2020
Q2
$24.9M Buy
998,374
+73,780
+8% +$1.84M 0.06% 95
2020
Q1
$19.6M Buy
924,594
+485,000
+110% +$10.3M 0.08% 87
2019
Q4
$9.76M Sell
439,594
-63,128
-13% -$1.4M 0.04% 80
2019
Q3
$11.4M Buy
502,722
+281,722
+127% +$6.41M 0.04% 84
2019
Q2
$4.23M Buy
+221,000
New +$4.23M 0.02% 99